- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
Chapter 13 |
499 |
|
|
Neuropathic bladder
Innervation of the lower urinary tract (LUT) 500 Physiology of urine storage and micturition 504 Bladder and sphincter behavior in the patient with
neurological disease 506
The neuropathic lower urinary tract: clinical consequences of storage and emptying problems 508
Bladder management techniques for the neuropathic patient 510
Catheters and sheaths and the neuropathic patient 516 Management of incontinence in the neuropathic patient 518 Management of recurrent urinary tract infections (UTIs) in
the neuropathic patient 520
Management of hydronephrosis in the neuropathic patient 522
Management of autonomic dysreflexia in the neuropathic patient 523
Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease 524
Neuromodulation in lower urinary tract dysfunction 528
500 CHAPTER 13 Neuropathic bladder
Innervation of the lower urinary tract (LUT)
Motor innervation of the bladder
Parasympathetic motor innervation of the bladder
This neural pathway is primarily responsible for stimulating detrusor contractions, and to a lesser degree, relaxation of the bladder outflow region (bladder neck and urethra).
Preganglionic, parasympathetic nerve cell bodies are located in the intermediolateral column of spinal segments S2–4. These preganglionic, parasympathetic fibers pass out of the spinal cord through the anterior primary rami of S2, S3, and S4 and, contained within nerves called the nervi erigentes, they head toward the pelvic plexus. In the pelvic plexus (in front of the piriformis muscle) the preganglionic, parasympathetic fibers synapse, within ganglia, with the cell bodies of the postganglionic parasympathetic nerves, which then run to the bladder and urethra.
Half of the ganglia of the pelvic plexus lie in the adventitia of the bladder and bladder base (the connective tissue surrounding the bladder), and 50% are within the bladder wall. The postganglionic axons provide cholinergic excitatory input to stimulate contraction of the smooth muscle of the bladder.
Sympathetic motor innervation of the bladder
The primary role of the sympathetic innervation is to contract the bladder base and the urethra.
In the male, preganglionic sympathetic nerve fibers arise from the intermediolateral column of T10–12 and L1–2. These preganglionic neurons synapse in the sympathetic chain, and postganglionic sympathetic nerve fibers travel as the hypogastric nerves to innervate the trigone, blood vessels of the bladder and the smooth muscle of the prostate and preprostatic sphincter (i.e., the bladder neck).
In the female, there is sparse sympathetic innervation of the bladder neck and urethra, with the major continence mechanism being the external sphincter.
In both sexes, some postganglionic sympathetic nerves also terminate in parasympathetic ganglia (in the adventitia surrounding the bladder and within the bladder wall) and exert an inhibitory effect on bladder smooth muscle contraction.
Afferent innervation of the bladder
Afferent nerves from receptors throughout the bladder ascend with parasympathetic neurons back to the cord and from there up to the pontine storage and micturition centers or to the cerebral cortex. They sense bladder filling.
Other receptors are located in the trigone, and afferent neurons from these neurons ascend with sympathetic neurons up to the thoracolumbar cord and from there to the pons and cerebral cortex.
INNERVATION OF THE LOWER URINARY TRACT (LUT) 501
Additionally, afferent receptors are located in the urethra. The afferent neurons pass through the pudendal nerve and again ascend to the pons and cerebral cortex. All these neurons have local relays in the cord.
Somatic motor innervation of the urethral sphincter: the distal urethral sphincter mechanism
Anatomically, this is located slightly distal to the apex of the prostate in the male (between the verumontanum and proximal bulbar urethra) and in the mid-urethra in the female. It has three components:
•Extrinsic skeletal muscle. This is the outermost layer, the pubourethral sling (part of levator ani). It is composed of striated muscle and innervated by the pudendal nerve (spinal segments S2–4, somatic nerve fibers). It is activated under conditions of stress and augments urethral occlusion pressure.
•Smooth muscle within the wall of the urethra. Cholinergic innervation. This is tonically active and relaxed by nitric oxide.
•Intrinsic striated muscle (i.e., skeletal muscle within the wall of the urethra, hence known as the intrinsic rhabdosphincter). It forms a U shape around the urethra, around the anterior and lateral aspects of the membranous urethra, and is absent posteriorly (i.e., it does not completely encircle the membranous urethra). It may produce
urethral occlusion by kinking the urethra rather than by circumferential compression.
Preganglionic somatic nerve fibers (i.e., neurons that innervate striated muscle) are, along with parasympathetic nerve fibers (which innervate the bladder), derived from spinal segments S2–4, specifically from Onuf nucleus (also known as spinal nucleus X), which lies in the medial part of the anterior horn of the spinal cord.
Onuf nucleus is the location of the cell bodies of somatic motoneurons that provide motor input to the striated muscle of the pelvic floor—the external urethral and anal sphincters. These somatomotor nerves travel to the rhabdosphincter via the perineal branch of the pudendal nerve (documented by direct stimulation studies and horseradish peroxidase [HRP] tracing, which accumulates in Onuf nucleus following injection into either the pudendal or pelvic nerves).
There also seems to be some innervation to the rhabdosphincter from branches of the pelvic plexus (specifically the inferior hypogastric plexus) via pelvic nerves. In dogs, complete silence of the rhabdosphincter is seen only if both the pudendal and pelvic efferents are sectioned. Thus, pudendal nerve block or pudendal neurectomy does not cause incontinence.
The nerve fibers that pass distally to the distal sphincter mechanism are located in a dorsolateral position (5 and 7 o’clock). More distally, they move to a more lateral position.
Consequences of damage to the nerves innervating the LUT are provided in Box 13.1.
502 CHAPTER 13 Neuropathic bladder
Box 13.1 Clinical consequences of damage to the nerves innervating the LUT
Clinical focal neurological examination for nerve pathways
•Motor function
•Tibialis anterior (L4–S1): controls dorsiflexion of foot
•Gastrocnemius (L5–S2): controls plantarflexion of foot
•Toe extensors (L5–S2): controls toe extension
•Sensory function: perianal/perineal sensation S2/S3
Reflexes
•Anal reflex (S2–5)
•Gently stroke mucocutaneous junction of circumanal skin
•If visible contraction (anal “wink”) absent, suggests peripheral nerve or sacral (conus medullaris) abnormality
•Bulbocavernosus reflex (BCR) (S2–4)
•Elicited by squeezing glans to cause reflex contraction of anal sphincter
•Absence of BCR suggests sacral nerve damage
Bladder neck function in the female
Approximately 75% of continent young women and 50% of perimenopausal continent women have a closed bladder neck during the bladderfilling phase. 25% of continent young women and 50% of perimenopausal continent women have an open bladder neck and yet they remain continent (because of their functioning distal sphincter mechanism, the external sphincter).1,2
Presacral neurectomy (to destroy afferent pain pathways) does not lead to incontinence because of maintenance of the somatic innervation of the external sphincter.
Sympathetic motor innervation of the bladder
Division of the hypogastric plexus of nerves during procedures such as a retroperitoneal lymph node dissection for metastatic testis tumors results in paralysis of the bladder neck. This is of significance during ejaculation, where normally sympathetic activity results in seminal emission and closure of the bladder neck so that the ejaculate is directed distally into the posterior and then anterior urethra.
If there is failure of emission or the bladder neck is incompetent, the patient develops retrograde ejaculation. They remain continent of urine because the distal urethral sphincter remains functional, being innervated by somatic neurons from S2–4.
During pelvic fracture, the external sphincter and/or its somatic motor innervation may be damaged, such that it is incompetent and unable to maintain urinary continence. Preservation of bladder neck function (the sympathetic innervation of the bladder neck usually remains intact) can preserve continence. However, if in later life the patient undergoes a TURP or bladder neck incision for symptomatic prostatic obstruction, they may well be rendered incontinent because their one remaining sphincter mechanism (the bladder neck) will be divided during these operations.
INNERVATION OF THE LOWER URINARY TRACT (LUT) 503
Sensory innervation of the urethra
Afferent neurons from the urethra travel in the pudendal nerve. Their cell bodies lie in the dorsal root ganglia, and they terminate in the dorsal horn of the spinal cord at S2–4, connecting with neurons that relay somatic sensory information to the brainstem and cerebral cortex.
The pudendal nerve—a somatic nerve derived from spinal segments S2–4—innervates striated muscle of the pelvic floor (levator ani—i.e., the pubourethral sling). Bilateral pudendal nerve block1 does not lead to incontinence because of maintenance of internal (sympathetic innervation) and external sphincter function (somatic innervation, S2–4, nerve fibers traveling to the external sphincter alongside parasympathetic neurons in the nervi erigentes).
1 Chapple CR, et al. (1989). Asymptomatic bladder neck incompetence in nulliparous females. Br J Urol 64:357–359.
2 Versi E, et al. (1990). Distal urethral compensatory mechanisms in women with an incompetent bladder neck who remain continent and the effect of the menopause. Neurourol Urodyn 9:579–590.